Get startedLog in
    Picture of HBM Holdings logo

    2142 — HBM Holdings News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapMomentum Trap
    All News

    Brief: Harbour Biomed Signs License Agreement With Windward Bio For HBM9378

    Picture of HBM Holdings logoHBM Holdings
    10/01/2025 13:43
    Jan 10 (Reuters) - Hbm Holdings Ltd  2142.HK :
    * HARBOUR BIOMED ANNOUNCES LICENSE AGREEMENT WITH WINDWARD
BIO FOR
HBM9378/SKB378, AN ANTI-TSLP FULLY HUMAN ANTIBODY FOR
IMMUNOLOGICAL DISEASES
    * HBM HOLDINGS LTD - HARBOUR BIOMED AND KELUN-BIOTECH
ELIGIBLE FOR
UP TO $970 MILLION UPFRONT AND MILESTONE PAYMENTS
    * HBM HOLDINGS: $45 MILLION UPFRONT & NEAR-TERM MILESTONE
PAYMENTS
INCLUDE BOTH CASH PAYMENT & EQUITY INTEREST IN WINDWARD BIO'S
PARENT COMPANY

Source text:  urn:newsml:reuters.com:*:nPn53cXSja
Further company coverage:  2142.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HBM Holdings

    See all news